NCT04835233View on ClinicalTrials.gov

Management of Hypertension in the Early Postpartum: a Randomized Controlled Trial

PHASE4CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

May 1, 2021

Primary Completion Date

December 16, 2022

Study Completion Date

December 31, 2022

Conditions
Pregnancy-Induced Hypertension in PostpartumPostpartum Pre-EclampsiaHypertension
Interventions
DRUG

Methyldopa 250 MG

maintaining postpartum the use of methyldopa 250 mg 01 tablet every 8 hours, being able to double the dose depending on pressure levels, up to 15 days postpartum

Trial Locations (1)

58050-585

UFPB Paraíba Federal University, João Pessoa

All Listed Sponsors
lead

Federal University of Paraíba

OTHER